Table 4.
Clinical variables of 18 patients.
| No. | Age | FIGO | Lymph Node |
WPRT (Gy) |
CDDP (Times) |
Pre- Treatment Volume (cm3) |
HR-CTV Volume (cm3) |
HR-CTV D90 (Gy) |
HR-CTV D100 (Gy) |
Bladder D2cc (Gy) |
Rectal D2cc (Gy) |
Recurrent | Late Complications Grade ≥ 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 24 | IIB | positive | 30 | 4 | 130.2 | 30 | 79.6 | 71.8 | 70 | 74 | none | VO (grade 2) |
| 2 | 67 | IIB | positive | 40 | 5 | 84.9 | 17.5 | 94.7 | 80 | 64.8 | 56.9 | none | |
| 3 | 70 | IIB | negative | 30 | 4 | 31.4 | 21.4 | 82.6 | 70.9 | 67.4 | 68.7 | none | RVF (grade 3) |
| 4 | 82 | IIB | positive | 40 | 0 | 43.6 | 23.7 | 92.6 | 80 | 77.4 | 81.3 | PALN | RB (grade 3) |
| 5 | 35 | IIIB | negative | 30 | 5 | 77.8 | 63.6 | 84.7 | 70 | 75.4 | 58 | none | |
| 6 | 49 | IIIB | positive | 30 | 3 | 208.4 | 147 | 94.7 | 80 | 94 | 85.4 | DLN | |
| 7 | 53 | IIIB | positive | 30 | 5 | 54.2 | 36.3 | 88.9 | 70 | 70 | 53.8 | none | VO (grade 2) |
| 8 | 69 | IIIB | positive | 40 | 5 | 190.7 | 133 | 96.8 | 80 | 82.6 | 73.8 | none | RB (grade 2) |
| 9 | 71 | IIIB | negative | 30 | 1 | 69.2 | 84.8 | 85.7 | 70 | 84 | 70 | none | RB (grade 2) |
| 10 | 72 | IIIB | negative | 30 | 5 | 53.1 | 33.1 | 82.6 | 70 | 68.7 | 63.1 | none | |
| 11 | 79 | IIIB | negative | 30 | 0 | 45.7 | 38.4 | 93.6 | 80 | 68 | 82.6 | DIS | |
| 12 | 48 | IVA | negative | 40 | 5 | 108.4 | 41.8 | 98.2 | 79.6 | 102.9 | 52.6 | none | |
| 13 | 62 | IVA | positive | 40 | 5 | 90.2 | 62.3 | 97.8 | 80 | 118.8 | 72.6 | none | |
| 14 | 62 | IVA | positive | 40 | 0 | 266.7 | 30 | 95.7 | 80 | 103.4 | 81.3 | none | SP (grade 3) |
| 15 | 68 | IVA | negative | 40 | 4 | 60.1 | 42.6 | 100 | 80 | 115.2 | 77.4 | none | RB (grade 2) |
| 16 | 77 | IVA | positive | 40 | 1 | 121.2 | 46.1 | 97.8 | 80 | 129.9 | 78.7 | none | |
| 17 | 41 | IVB | positive | 45 | 5 | 152 | 86.2 | 87.8 | 76.3 | 82.4 | 75.2 | none | RB (grade 2) |
| 18 | 54 | IVB | positive | 45 | 2 | 129 | 48.9 | 88.7 | 76.2 | 83.7 | 69.8 | none |
Abbreviation: WPRT = whole pelvic external beam radiotherapy; HR-CTV = high-risk clinical target volume; PALN = pala-aortic lymph node; DLN = distant lymph node; DIS = dissemination; VO = vaginal obstruction; RVF = recto-vaginal fistula; RB = rectal bleeding; SP; sigmoid colon perforation.